Evidence map›Paper›PMID 32488067›Full record

ArticleScientific reports2020

A copper-dependent compound restores ampicillin sensitivity in multidrug-resistant Staphylococcus aureus.

Cameron L Crawford, Alex G Dalecki, Mildred D Perez, Kaitlyn Schaaf, Frank Wolschendorf, Olaf Kutsch

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.4field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The promise of copper ionophores as antimicrobials.Current opinion in microbiology · 2023
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Experimental Evolution of Copper Resistance inAntibiotics (Basel, Switzerland) · 2022
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Cameron L CrawfordDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Alex G DaleckiDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Mildred D PerezDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Kaitlyn SchaafDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Frank WolschendorfDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Olaf KutschDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. okutsch@uab.edu.
University of Alabama at Birmingham · US

Funding

HTS for copper-activated inhibitors against MRSAR01AI121364 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KUTSCH, OLAF · 2016 to 2018
$2.2M
Identification of drugs that induce terminal transcriptional silencing of latent HIV-1 infectionR33AI133679 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KUTSCH, OLAF · 2020 to 2021
$1.4M
Kinomic analysis of host cell factors controlling latent HIV-1 infectionR33AI116188 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KUTSCH, OLAF · 2016 to 2018
$1.3M
Overcoming HIV-1 transcriptional latency in unresponsive CD4 T cellsR56AI122842 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KUTSCH, OLAF · 2016 to 2016
$455k
NIAID NIH HHS R01 AI121364NIAID NIH HHS R33 AI116188NIAID NIH HHS R33 AI133679NIAID NIH HHS R56 AI122842
6 · The paper itself

Abstract

Multi-drug resistant Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA), has become a worldwide, major health care problem. While initially restricted to clinical settings, drug resistant S. aureus is now one of the key causative agents of community-acquired infections. We have previously demonstrated that copper dependent inhibitors (CDIs), a class of antibiotics that are only active in the presence of copper ions, are effective bactericidal agents against MRSA. A second-generation CDI, APT-6K, exerted bactericidal activity at nanomolar concentrations. At sub-bactericidal concentrations, it effectively synergized with ampicillin to reverse drug resistance in multiple MRSA strains. APT-6K had a favorable therapeutic index when tested on eukaryotic cells (TI: > 30) and, unlike some previously reported CDIs, did not affect mitochondrial activity. These results further establish inhibitors that are activated by the binding of transition metal ions as a promising class of antibiotics, and for the first time, describe their ability to reverse existing drug resistance against clinically relevant antibiotics.

Indexed as

AmpicillinAnti-Bacterial AgentsBiofilmsCopperDrug Resistance, MultipleDrug SynergismHumansMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsStaphylococcal InfectionsStaphylococcus aureusAmpicillinAnti-Bacterial AgentsCopper

Identifiers

PMID32488067
PMCPMC7265353
OpenAlexW3030471300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.